Neil Kennedy joined Rebus Biosystems as Chief Commercial Officer in January 2021, bringing 25 years commercial experience in the life science industry with a proven track record of developing and commercializing transformational products and services for the basic, translational and clinical research markets. Most recently, Neil was Senior Vice President Commercial Operations at Dovetail Genomics. Prior to that, Neil held leadership positions as VP Sales and Marketing for Biodesy, VP Commercial Operations for Fluidigm, and VP Sales and Marketing for DVS Sciences (acquired by Fluidigm). Previously, Neil held sales leadership positions at Sequenom, Millipore and Quantum Dot (acquired by Life Technologies). Neil received his B.S. Degree in Biological Sciences from California State University, Chico.